| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 18, 2018
DUBLIN - May 18, 2018 - Medtronic plc (NYSE:MDT) announced today that the company will host its biennial Institutional Investor and Analyst Meeting on Tuesday, June 5, 2018, in New York City from...
-
May 16, 2018Medtronic Received IDE Approval from FDA to Generate Clinical Evidence with Resolute Onyx DES to Support Future Application for Expanded Indication in U.S.
DUBLIN - May 16, 2018 - Medtronic plc (NYSE: MDT) today announced the initiation of a clinical study in the U.S. to assess the safety and efficacy of drug-eluting stents (DES) for the treatment of...
-
May 15, 2018Real-World Data on AdaptivCRT(TM) Algorithm Presented at Heart Rhythm 2018
DUBLIN - May 15, 2018 - Medtronic plc (NYSE: MDT) announced study results showing its exclusive AdaptivCRT(TM) algorithm is associated with improved patient survival. The data were recently...
-
May 11, 2018Late-Breaking Presentation at Heart Rhythm 2018 Highlights Investigational Experience with ICD Lead Placed Under Sternum, Outside the Heart and Veins
DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE:MDT) today announced results from a research study demonstrating the feasibility of a novel approach to delivering pacing and defibrillation...
-
May 11, 2018Late-Breaking Presentation at Heart Rhythm 2018 Shows Potential for More Patients to Benefit from World's Smallest Pacemaker
DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the...
-
May 10, 2018
DUBLIN - May 10, 2018 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its fourth quarter and fiscal year 2018 on Thursday, May 24, 2018. A news release will...
-
May 9, 2018Results Presented at Heart Rhythm 2018 Also Show Leadless Pacemaker is Safe Option for Patients with Past Device Infection
DUBLIN and BOSTON - May 9, 2018 - Medtronic plc (NYSE: MDT) today announced that results through 12-months from the Post-Approval Registry (PAR) for the Medtronic Micra(TM) Transcatheter Pacing...
-
May 7, 2018
DUBLIN - May 7, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the appointment of Mike Weinstein as Senior Vice President, Strategy. In this role,...
-
May 2, 2018Integrated Technologies Allow a Fully Navigated Procedure with Fewer Surgical Steps
DUBLIN and NEW ORLEANS - May 2, 2018 - Medtronic plc (NYSE: MDT) today announced the advanced SynergyTLIFSM workflow - a procedural solution for spine surgery that combines innovative technologies...
-
May 1, 2018Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy.
DUBLIN - May 1, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval for Medtronic'